HOKKAIDO UNIVERSITY HOSPITAL

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Employees: -

Market Cap: -

Website: https://www.huhp.hokudai.ac.jp/

Clinical Trials

Intracerebral Transplantation of Autologous MSC Combined With Scaffold Product for Chronic Intracerebral Hemorrhage

Phase 1

Recruiting

Conditions: Intracerebral Hemorrhage

Interventions: Drug: HUFF-01

First Posted Date: 2024-04-11

Last Posted Date: 2024-04-11

Lead Sponsor: Hokkaido University Hospital

Target Recruit Count: 8

Registration Number: NCT06361433

Locations: 🇯🇵
Hokkaido University Hospital, Sapporo, Hokkaido, Japan

Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma

Phase 2

Recruiting

Conditions: Effect of Drug

Interventions: Drug: Docetaxel
Drug: Pembrolizumab

First Posted Date: 2022-02-23

Last Posted Date: 2024-10-02

Lead Sponsor: Hokkaido University Hospital

Target Recruit Count: 27

Registration Number: NCT05252429

Locations: 🇯🇵
Hokkaido University Hospital, Sapporo, Hokkaido, Japan

Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases

Completed

Conditions: Brain Metastasis

First Posted Date: 2006-12-04

Last Posted Date: 2006-12-04

Lead Sponsor: Hokkaido University Hospital

Target Recruit Count: 180

Registration Number: NCT00406835

Locations: 🇯🇵
Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy